Lactobacillus salivarius strain GSC and application thereof

By isolating the Lactobacillus salivary strain GSC from the buffalo rumen and optimizing the lyophilization process, the problem of isolated CLA strains in the rumen of ruminants was solved, significantly improving the yield and digestibility of CLA, providing excellent strains for CLA functional foods and Efficient production method.

CN118995488APending Publication Date: 2024-11-22GUANGXI ZHUANG AUTONOMOUS REGION BUFFALO INST
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411083441.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-08
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

The prior art is difficult to efficiently isolate highly conjugated linoleic acid (CLA) strains from ruminants of ruminants, and the strict anaerobicity and the relationship between rumen microorganisms lead to difficulties in isolation and purification, affecting the content and quality of CLA in milk meat products. .

Method used

GSC strain Ligilactobacillus salivarius was isolated from the buffalo rumen, and the lyophilized powder activity and CLA yield of the strain were improved by improving the lyophilized process, combining sodium glutamate, algae oligosaccharide, skim milk and sucrose as activators and lyophilized protective agent to optimize the preparation conditions of lyophilized powder.

Benefits of technology

It significantly improves the yield and digestibility of CLA in buffalo rumen, improves the survival ability and CLA yield of strains, provides excellent strains and efficient CLA production methods for CLA functional food development.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118995488A_ABST
    Figure CN118995488A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of microorganisms, in particular to a lactobacillus salivarius strain GSC and application thereof.The GSC strain is separated from gastric tumor of buffalo, the strain has high conjugated linoleic acid (CLA) production capacity, fermentation experiments show that the strain has a remarkable improvement effect on digestibility of nutrient substances in rumen of in-vitro fermented buffalo, and the production efficiency of the buffalo is improved. The effect of remarkably improving in-vitro fermentation of buffalo rumen fatty acid of buffalo is achieved; after the strain is prepared into freeze-dried powder, the survival ability of the strain can be remarkably improved under the action of an activating agent and a freeze-dried powder protective agent, so that the yield of conjugated linoleic acid (CLA) of the freeze-dried powder of the strain is improved, and the optimal preparation conditions of the freeze-dried powder are further obtained through orthogonal optimization.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The invention relates to the technical field of microorganisms, in particular to a Lactobacillus salivarius strain GSC and an application thereof. [Background technology]

[0002] With the rapid improvement of economic level, health care has become the focus of public attention, among which food therapy health care has become a new concept for contemporary people. While pursuing nutritious and delicious food, people also want to prevent diseases and promote health. Conjugated linoleic acid (CLA) functional food has entered the public's field of vision. CLA refers to the general term for octadecadienoic acid isomers containing conjugated double bonds. It is the most important functional fatty acid discovered by humans in the past 30 years. Studies have found that the two isomers of c9, t11-CLA and t10, c12-CLA have important biological functions, such as reducing skin infections, treating diabetes, promoting bone growth and development, resisting atherosclerosis, delaying body aging, resisting hypertension, reducing asthma, fighting cancer, regulating immune function, and reducing fat. Under certain conditions, the human body can produce a small amount of CLA that is insufficient to meet physiological needs through endogenous pathways. In order to meet the needs of human body tissues, it needs to be supplemented by intake. Dairy products and meat products are the main sources of CLA in people's daily lives. Therefore, most domestic and foreign scholars are keen on studying how to increase the CLA content in milk and meat and synthesize a new type of functional products more efficiently. At present, there are two main methods for commercial production of CLA. One is chemical synthesis, but the chemical method cannot synthesize specific CLA, and the isomer composition of the synthesized CLA is quite different from that of natural food. When producing multiple isomers, other toxic byproducts are often accompanied, which limits its application in the field of food and medicine. Another method is microbial transformation. On the one hand, CLA can be prepared through microbial engineering, and on the other hand, the isolated CLA high-yielding strains and linoleic acid isomerase can be directly used for the production of fermented dairy products, thereby greatly increasing the CLA content in the corresponding products. The characteristics of certain microorganisms can produce relatively natural and single CLA isomers, and conjugated linoleic acid with certain physiological functions can be prepared in a targeted manner. It has certain advantages in producing food-grade conjugated linoleic acid, so the microbial transformation method has received increasing attention from scholars.

[0003] Different animals contain different amounts or types of CLA, and the differences are great. Among them, the CLA content in ruminant meat and milk products is the highest. It has been reported that the quality of buffalo milk is better than other milk, and the CLA content is significantly higher than that of Holstein cows, Simmental cows and Jersey cows. The c9, t11-CLA content in buffalo milk can reach 4.59 mg / 100g milk. Buffalo milk and meat products have the potential to be developed into high-CLA functional foods. There are two main sources of CLA in ruminants: c9, t11-CLA produced during the metabolic process of linoleic acid to stearic acid (C18:0) by rumen microorganisms, and c9, t11-CLA is directly generated by vaccenic acid (C18:1, trans-11) in the mammary gland through the action of Δ9 dehydrogenase. After a long period of evolution, rumen microorganisms and ruminants have become a mutually beneficial symbiotic relationship, and rumen microorganisms can metabolize fatty acids, thereby affecting the fatty acid composition contained in ruminant milk and meat. The high CLA content in buffalo milk may be related to the number and activity of certain microorganisms in the rumen, but there has been no report on the isolation of CLA-producing strains from the rumen of buffaloes. Therefore, this study was carried out to isolate and screen high-CLA-producing strains from the rumen of buffaloes, and observe the ability of the selected target strains to metabolize linoleic acid and the effect on rumen fermentation parameters through in vitro and in vivo fermentation tests. On the one hand, it provides a basis for increasing the CLA content of ruminant products, promoting the quality of dairy and meat products, and improving human health. On the other hand, it can enrich the CLA-producing strain library and provide more excellent strains for the development of CLA functional foods in the later stage.

[0004] At present, there are more than 250 strains that have the ability to synthesize CLA, and these strains belong to 14 genera, including Micrococcus, Enterococcus, Fungus, Pediococcus, Propionibacterium and Lactobacillus. Among them, rumen bacteria, propionibacteria and lactobacillus have a high conversion rate of CLA synthesis. The main source of pure natural CLA in nature is produced by rumen bacteria, and rumen microorganisms are the first microorganisms discovered to have the ability to produce CLA. Although there are many strains that can synthesize CLA, the number of microorganisms with the ability to hydrogenate unsaturated fatty acids isolated and identified from the rumen of ruminants is very small. Currently, there are only some strains of Butyrivibrio fibrinolyticus, Fungus, Ruminococcus albus and Fusocillus. The reason why there are few CLA-producing strains isolated and identified from the rumen is that most of the microorganisms in the rumen are strictly anaerobic bacteria, and it is difficult to ensure a strict anaerobic environment during the separation and purification process. In addition, there are many cases where other bacteria coexist in many colonies. This companion relationship has caused great difficulties for separation and purification. Therefore, it is necessary to accelerate the isolation of high-CLA-producing strains from the rumen of buffaloes and identify their species through morphological and molecular biology techniques, and finally study the ability of the target high-CLA-producing strains to metabolize linoleic acid and its effect on rumen fermentation parameters through in vitro and in vivo fermentation methods. This is of great significance for improving the quality of ruminant products and can provide excellent strains for the development of CLA functional products. [Summary of the invention]

[0005] In view of the above, it is necessary to provide a strain that can produce high CLA, and at the same time improve the activity of the strain freeze-dried powder by improving the freeze-drying process.

[0006] In order to achieve the above object, the technical solution adopted by the present invention is:

[0007] The present invention comprises a Lactobacillus salivarius strain GSC, whose preservation number is CCTCCNO: M20241407. The strain is preserved in the General Microbiology Center of China Microorganism Culture Collection Administration, address: Wuhan University, Wuhan, China, with a preservation number of CCTCC NO: M20241407 and a preservation date of July 1, 2024.

[0008] The present invention also includes a lyophilized powder comprising the Ligilactobacillus salivarius strain GSC.

[0009] The present invention also includes an application of the Lactobacillus salivarius strain GSC and / or the freeze-dried powder in increasing the yield of conjugated linoleic acid.

[0010] The present invention also includes the use of the Lactobacillus salivarius strain GSC and / or the freeze-dried powder in improving the digestibility of buffalo.

[0011] The present invention also includes the use of the Lactobacillus salivarius strain GSC and / or the freeze-dried powder in preparing buffalo feed.

[0012] The present invention also includes a method for preparing the lyophilized powder containing the Lactobacillus salivarius strain GSC, the method comprising the following steps:

[0013] (1) After the strain GSC is inoculated into a culture medium, the activator is added thereto for one subculture activation, and then the strain GSC is inoculated into an expansion culture medium at an inoculum amount of 2% (v / v) for cultivation, the fermentation liquid is divided and centrifuged, the supernatant fermentation liquid is removed, and physiological saline is added to resuspend the liquid, and the centrifugation is repeated to obtain bacterial sludge; the bacterial sludge is mixed and shaken with a freeze-dried protective agent solution having a volume percentage of 20% of the original fermentation liquid volume to make it uniform, thereby preparing a bacterial suspension;

[0014] (2) Prefreezing: Pour the bacterial suspension into a sterile culture dish to a thickness of about 0.5 cm and prefreeze at -80°C for 12 h;

[0015] (3) Vacuum freeze drying: After the bacterial slurry is pre-frozen, freeze-dry it for 24 hours to make the moisture content of the freeze-dried bacterial powder about 3%, thus obtaining freeze-dried powder.

[0016] Furthermore, the activator in step (1) is sodium glutamate with a concentration of 0.05 g / L-0.15 g / L and / or brown algae oligosaccharide with a concentration of 0.1 g / L-0.2 g / L.

[0017] Furthermore, the lyophilization protective agent in step (1) is skim milk with a concentration of 30-40 g / 100 mL and / or sucrose with a concentration of 10-14 g / 100 mL.

[0018] The present invention has the following beneficial effects:

[0019] 1. The GSC strain of the present invention is isolated from the gastric tumor of buffalo. The strain has a high ability to produce conjugated linoleic acid (CLA). Fermentation experiments have found that the strain has a significant effect on improving the digestibility of nutrients in the rumen of buffalo in vitro fermentation, and has a significant effect on improving the rumen fatty acids (including saturated fatty acids, unsaturated fatty acids, total fatty acids, and total conjugated linoleic acid) of buffalo in vitro fermentation; after the strain is prepared into freeze-dried powder, under the action of an activator and a freeze-dried powder protective agent Under the conditions of 10% to 20% lyophilized water, the survival ability of the strain can be significantly improved, thereby increasing the conjugated linoleic acid (CLA) yield of the strain freeze-dried powder. After orthogonal optimization, the present application also obtained the optimal reaction conditions of the freeze-dried powder: the activator is sodium glutamate with a concentration of 0.05g / L-0.15g / L and / or brown algae oligosaccharides with a concentration of 0.1g / L-0.2g / L; the lyoprotectant is skim milk with a concentration of 30-40g / 100mL and / or sucrose with a concentration of 10-14g / 100mL.

Brief Description of the Drawings

[0020] Figure 1 This is a diagram of the growth of the GSC strain on a plate of the present application.

[0021] Figure 2 This is a microscopic examination picture of the GSC strain according to an example of the present application under a microscope. [Specific implementation method]

[0022] All features disclosed in this specification, or steps in all methods or processes disclosed, except mutually exclusive features and / or steps, can be combined in any manner.

[0023] Any feature disclosed in this specification (including any appended claims and abstract), unless otherwise stated, is merely an example of a series of equivalent or similar features.

[0024] Example 1

[0025] This example is a method for screening Lactobacillus salivarius strain GSC:

[0026] (1) The strains of this embodiment were isolated, purified and cultured from the rumen of buffalo. 24 buffaloes were selected for the experiment. The concentration of conjugated linoleic acid (CLA) in the rumen fluid was measured, and the two buffaloes with the highest CLA concentration were selected as the research objects. The Henkel tube method and anaerobic operation technology (anaerobic bag) were used for 24 separation and purification. The concentration of conjugated linoleic acid (CLA) in the gastric fluid of the 24 strains was shown in Table 1. Nine pure strains were isolated and screened from the rumen of the two buffaloes with the highest CLA concentration. Two buffaloes with the highest CLA concentration were selected, and the bacteria were separated and purified from the rumen fluid of the buffaloes. After 24 separation and purification, nine rumen bacteria were isolated and numbered A, B, C, D, E, F, G, H, and K.

[0027] (2) Three CLA-producing strains were preliminarily screened from nine anaerobic bacteria in the rumen of buffaloes, and their species identification was performed. Exogenous linoleic acid (0.25 mg / mL) was added to the culture medium, and the nine isolated anaerobic bacteria were inoculated. After culturing for 24 h, three CLA-producing strains were preliminarily screened by detecting CLA in the fermentation broth, which were numbered C, G, and H.

[0028] (3) Three strains, C, G and H, with strong CLA production capacity were selected and their species were determined by morphological observation, physiological and biochemical characteristics, gene sequencing and other methods. Finally, strain C was named GSC and patented and identified as follows:

[0029] Morphological characteristics: After the GSC strain was cultured anaerobically on solid medium for 48 hours, the colony morphology was Figure 1 The nutrient solution was used for liquid anaerobic culture. The culture solution was uniformly turbid with bacterial sediment at the bottom, indicating that the bacteria were anaerobic or facultative anaerobic. The selected bacteria were smeared with Gram stain and observed under an optical microscope. The results of Gram staining microscopic examination of cell morphology are shown in Figure 2 The colony diameter is 2-3mm, the colony is milky white, the colony surface has single colony protrusions, the surface is smooth, moist and opaque, the edges are neat, Gram-positive rods, purple, short rod-shaped, with blunt ends, arranged singly or in pairs, with obvious morphological characteristics of Lactobacillus salivarius.

[0030] Molecular identification: The sequencing results of the 16S rDNA amplification product of the GSC strain are shown in Sequence Table 1 (SEQ ID NO. 1). Through BLAST similarity comparison analysis in the NCBI database (Table 1), the similarity between the GSC strain and Ligilactobacillus salivarius reached 100%, so the GSC strain was identified as Ligilactobacillus salivarius.

[0031] Table 1 Comparison of ITS rDNA sequence similarity between GSC strains and other known bacteria in GenBank

[0032] Strain number PCR product length / bp Related species Similarity % Closely related species accession number GSC 1352 Ligilactobacillus salivarius 100 MT613610.1

[0033] Based on the above factors, the strain GSC of the present application is identified as Ligilactobacillus salivarius. The Lactobacillus salivarius is deposited in the General Microbiology Center of China Microbiological Culture Collection Administration, address: Wuhan University, Wuhan, China, with a deposit number of CCTCC NO: M20241407 and a deposit date of July 1, 2024.

[0034] Example 2

[0035] The physiological and biochemical characteristics of the strain GSC in this example were identified.

[0036] The fermentation results of carbohydrates of API 50CH biochemical identification kit are shown in Table 2.

[0037] Table 2 Fermentation results of carbohydrate API 50CH of strain GSC

[0038]

[0039]

[0040]

[0041] Note: “+” indicates a positive result; “-” indicates a negative result.

[0042] Example 3

[0043] The present embodiment studies the influence of bacterial strain GSC on the in vitro fermentation of buffalo rumen: the in vitro fermentation substrate is selected as elephant grass (500mg), the linoleic acid solution after emulsification is added in the culture bottle according to the corresponding setting ratio (final concentration 0.25mg / mL), the artificial rumen buffer and the rumen fluid volume 2:1 are mixed evenly, 60mL of mixed solution is extracted and added in the culture bottle (185mL), the target bacterial solution (GSC) identified is added by 10% inoculum size, and then sealed with rubber stopper and aluminum cap. The whole process is fed with CO2 gas to maintain anaerobic environment, and it is completed as soon as possible. The control group does not add bacterial solution, adds equal amount of distilled water, and 5 repetitions are added in each group, and the experimental design is shown in Table 3. Anaerobic culture under 37 ℃ condition. Each group should be cultured continuously for 72 hours, and the fermentation gas production and methane production should be detected by gas chromatography at 3h, 6h, 12h, 24h, 36h, 48h and 72h. After 72 hours, the culture medium should be placed on ice to stop fermentation and then the culture medium should be taken to detect indicators such as pH, VFA, lactic acid, NH3-N concentration, MCP content, medium and long-chain fatty acids, microbial quantity composition, and digestibility of fermentation substrate nutrients.

[0044] Table 3 Experimental design

[0045] Group Control group GSC strain group CON1 GSC1 CON2 GSC2 CON3 GSC3 CON4 GSC4 CON5 GSC5 Substrate 0.5g 0.5g Linoleic acid 0.25mg / mL 0.25mg / mL Buffer and rumen fluid 60mL 60mL Target bacterial solution 6.7 mL water 6.7mL

[0046] (2) The effects of adding GSC strain on the total gas production, total methane content and in vitro fermentation parameters of buffalo rumen in vitro fermentation are shown in Table 4.

[0047] Table 4 Effects of strain GSC on in vitro gas production and fermentation parameters in buffalo rumen

[0048]

[0049]

[0050] Note: Different letters in the same row mean that the results are significantly different (P<0.05), the same letters or no letters mean that the results are not significantly different (P>0.05), the same below.

[0051] As can be seen from Table 4, the 72h cumulative total gas production, methane production, pH, MCP content, NH3-N content, isobutyric acid content, isovaleric acid content, and valeric acid content of the GSC strain test group were significantly higher than those of the control group (P<0.05), but there were no significant differences in lactic acid, acetic acid, and propionic acid (P>0.05).

[0052] Example 4

[0053] This example studies the effect of adding GSC strain on the digestion of nutrients in the rumen of buffalo, as shown in Table 5.

[0054] Table 5 Effect of strains on rumen nutrient digestibility of buffalo in vitro fermentation (%)

[0055] Items CON GSC strains DMD dry matter digestibility 49.22b 59.04a CPD crude protein digestibility 2.28b 4.28a NDFD Neutral Detergent Fiber Digestibility 39.19b 43.72a ADFD acid detergent fiber digestibility 19.59b 22.55a

[0056] As shown in Table 5, the dry matter digestibility, CP digestibility, NDF and ADF digestibility of the GSC strain test group were significantly higher than those of the control group (P<0.05).

[0057] The effect of adding the GSC strain in this example on the in vitro fermentation of buffalo rumen fatty acids is specifically shown in Table 6.

[0058] Table 6 Effect of strain GSC on the content of long-chain fatty acids in the rumen of buffalo in vitro fermentation (ug / mL)

[0059]

[0060]

[0061] Note: SFA: total saturated fatty acids; USA: total unsaturated fatty acids; TFA: total fatty acids; TCLA: total conjugated linoleic acid.

[0062] SFA: C11:0+C12:0+C13:0+C14:0+C15:0+C16:0+C17:0+C18:0+C20:0+C21:0+C22:0+C23:0+C24:0;

[0063] UFA: C14:1+C15:1+C16:1+C17:1+C18:3N6+C18:2C12,T10+C18:1N9C+C18:1N9T+

[0064] C18:2C9,T11+C18:2N6C+C18:2N6T+C18:3N3+C18:1T+C20:5N3+C20:4N6+C20:3N6+C20:3N3+C20:2+C20:1+C22:6N3+C22:1N9+C24:1;

[0065] TFA: SFA+UFA; TCLA: C18:2C12,T10+C18:2C9,T11.

[0066] As can be seen from Table 6, the contents of C12:0, C14:0, C14:1, C15:1, C16:0, C17:0, C18:3N6, C18:1N9C, C18:2C9,T11, C18:2N6T, C18:1T, C18:0, C20:1, C20:0, C21:0, C22:6N3, C22:1N9, C24:0, C24:1, UFA, SFA, TFA and TCLA in the strain GSC experimental group were significantly higher than those in the control group (P<0.05).

[0067] The contents of C16:1, C17:1, C18:2C12, T10, C18:2N6C, C20:5N3, C20:4N6, C20:3N6, C20:3N3 and C22:0 were significantly lower than those in the control group (P<0.05).

[0068] There was no significant difference in the contents of C11:0, C13:0, C15:0, C18:1N9T, C18:3N3, C20:2 and C23:0 in the GSC experimental group compared with the control group (P>0.05).

[0069] Example 5

[0070] The preparation method of freeze-dried powder using strain GSC is as follows:

[0071] 1. Preparation of bacterial suspension, strain activation and culture: After the strain GSC is inoculated into the culture medium, the activators (sodium glutamate, brown algae oligosaccharide and polyglutamic acid) in Table 7 are added respectively. After one subculture activation, the strain GSC is inoculated into the expansion culture medium at an inoculum amount of 2% (v / v) for culture. After the fermentation liquid is divided and centrifuged, the supernatant fermentation liquid is removed and then added with physiological saline for resuspending. After repeated centrifugation, the bacterial mud is obtained; the bacterial mud is mixed and shaken with a lyophilization protective agent (35g / 100mL skim milk and 12g / 100mL sucrose) solution with a volume percentage of 20% of the original fermentation liquid volume to make it uniform, and a bacterial suspension is prepared.

[0072] 2. Prefreeze: Pour the bacterial suspension into a sterile culture dish with a thickness of about 0.5 cm and prefreeze at -80°C for 12 hours.

[0073] 3. Vacuum freeze drying: After the bacterial slurry is pre-frozen, freeze-dry it for 24 hours to make the moisture content of the freeze-dried bacterial powder about 3%, thus obtaining freeze-dried powder.

[0074] The survival rate and CLA production capacity of the freeze-dried powder were determined as follows:

[0075] (1) Survival rate determination: At 24 h, the number of viable Lactobacillus salivarius before freeze-drying and the number of viable Lactobacillus salivarius after freeze-drying of the same volume of bacterial slurry were determined.

[0076] Freeze-drying survival rate / % = (number of live bacteria in 1 mL of bacterial mud after freeze-drying) / (number of live bacteria in 1 mL of bacterial mud before freeze-drying)

[0077] (2) CLA production capacity: The freeze-dried powder was inoculated into MRS medium at a rate of 5% and cultured for 24 h for activation. The activated bacterial solution was then inoculated into an in vitro fermentation substrate, elephant grass (500 mg), at a rate of 5% for fermentation. After 72 h of fermentation, the CLA content was determined and calculated.

[0078] Table 7 Effects of activators on strain GSC

[0079]

[0080]

[0081] The test results are shown in Table 8:

[0082] Table 8 Effect of activators on strain GSC

[0083]

[0084] As can be seen from Table 8, when the concentration of sodium glutamate is between 0.05g / L-0.15g / L and the concentration of brown algae oligosaccharides is between 0.1g / L-0.2g / L, it can promote the growth of strain GSC and increase the production of CLA; when the concentration of sodium glutamate is between 0.2g / L-0.25g / L, it begins to inhibit the growth of strain GSC. When the concentration of brown algae oligosaccharides is at 0.05g / L, it does not promote the growth of strain GSC. No matter what the concentration of polyglutamate is, it will inhibit the growth of strain GSC and reduce the production of CLA.

[0085] In conjunction with this application, the concentrations of sodium glutamate, brown algae oligosaccharides, skim milk and sucrose were selected to design an orthogonal experiment, and the CLA production capacity of the strain GSC freeze-dried powder was detected; as shown in Tables 9 and 10:

[0086] Table 9 Levels of orthogonal experimental factors for CLA production by strain GSC

[0087]

[0088] The orthogonal analysis of the above ratios and the results thereof are shown in Table 10:

[0089] Table 10 Orthogonal experiment and results

[0090] Number of trials Monosodium glutamate Brown algae oligosaccharide Skim milk sucrose CLA yield (ug / mL) 1 A A A A 226.82 2 A B B B 221.51 3 A C C C 233.64 4 B A B C 246.84 5 B B C A 255.85 6 B C A B 264.53 7 C A C B 266.13 8 C B A C 263.57 9 C C B A 257.32 Mean 1 227.323 246.597 251.640 246.663 Mean 2 255.740 246.977 241.890 250.723 Mean 3 262.340 251.830 251.873 248.017 Very bad 35.017 5.233 9.983 4.060

[0091] As shown in Table 10, the CLA yield of Experiment 1-2 is lower than that of the control group in Table 8, the CLA yield of Experiment 3 is equivalent to that of the control group, and the CLA yield of Experiments 5-9 is above 250ug / mL, indicating that the above-mentioned activators and freeze-drying protective agents are significantly improved at the ratio of Experiments 5-9. At this time, the addition concentration of sodium glutamate is: 0.10g / L-0.15g / L; the addition concentration of brown algae oligosaccharide is 0.05g / L-0.15g / L; the addition amount of skim milk is 30g / 100mL-40g / 100mL; the addition amount of sucrose is 10g / 100mL-14g / 100mL. The optimal concentration is that the addition concentration of sodium glutamate in Experiment 7 is: 0.15g / L; the addition concentration of brown algae oligosaccharide is 0.05g / L; the addition amount of skim milk is 40g / 100mL; and the addition amount of sucrose is 12g / 100mL.

[0092] In summary, the preparation method of freeze-dried powder of strain GSC is as follows:

[0093] 1. Preparation of bacterial suspension, strain activation and culture: After the strain GSC is inoculated into the culture medium, 0.10g / L-0.15g / L of sodium glutamate and 0.05g / L-0.15g / L of brown algae oligosaccharide are added respectively. After one subculture activation, the strain GSC is inoculated into the expansion culture medium at an inoculum amount of 2% (v / v) for culture. After the fermentation liquid is divided and centrifuged, the supernatant fermentation liquid is removed and then added with physiological saline for resuspending, and the bacterial mud is obtained after repeated centrifugation; the bacterial mud is mixed and shaken with a lyophilization protective agent solution (30g / 100mL-40g / 100mL of skim milk and 10g / 100mL of sucrose) with a volume of 1 / 5 of the original fermentation liquid to make it uniform, and a bacterial suspension is prepared.

[0094] 2. Prefreeze: Pour the bacterial suspension into a sterile culture dish with a thickness of about 0.5 cm and prefreeze at -80°C for 12 hours.

[0095] 3. Vacuum freeze drying: After the bacterial slurry is pre-frozen, freeze-dry it for 24 hours to make the moisture content of the freeze-dried bacterial powder about 3%, thus obtaining freeze-dried powder.

[0096] In summary, the Lactobacillus salivarius GSC of the present application has a higher CLA production capacity, and can significantly improve the digestibility of the strain compared to other strains, can be used to be processed into feed, and can still maintain a high vitality after being prepared into freeze-dried powder after optimization of the protective agent, and also has a strong CLA production capacity. After orthogonal optimization under the joint action of the activator and the protective agent, its CLA production capacity is significantly improved.

[0097] The above-described embodiments only express several implementation methods of the present invention, and the description thereof is relatively specific and detailed, but it cannot be understood as limiting the scope of the present invention. It should be pointed out that, for a person of ordinary skill in the art, several modifications and improvements can be made without departing from the concept of the present invention, and these all belong to the protection scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the attached claims.

Claims

1. A strain of Lactobacillus salivarius GSC, whose deposit number is CCTCCNO: M20241407.

2. A freeze-dried powder comprising the Lactobacillus salivarius strain GSC as claimed in claim 1.

3. Use of the Lactobacillus salivarius strain GSC as claimed in claim 1 and / or the freeze-dried powder as claimed in claim 2 for increasing the yield of conjugated linoleic acid.

4. Use of the Lactobacillus salivarius strain GSC according to claim 1 and / or the freeze-dried powder according to claim 2 in improving the digestibility of buffaloes and increasing the fatty acids in in vitro fermentation of rumen fluid.

5. Use of the Lactobacillus salivarius strain GSC according to claim 1 and / or the freeze-dried powder according to claim 2 in preparing buffalo feed.

6. A method for preparing a freeze-dried powder containing the Lactobacillus salivarius strain GSC as claimed in claim 2, characterized in that: The method comprises the following steps: (1) After the strain GSC is inoculated into a culture medium, the activator is added thereto for one subculture activation, and then the strain GSC is inoculated into an expansion culture medium at an inoculum amount of 2% (v / v) for cultivation, the fermentation liquid is divided and centrifuged, the supernatant fermentation liquid is removed, and physiological saline is added to resuspend the liquid, and the centrifugation is repeated to obtain bacterial sludge; the bacterial sludge is mixed and shaken with a freeze-dried protective agent solution having a volume percentage of 20% of the original fermentation liquid volume to make it uniform, thereby preparing a bacterial suspension; (2) Prefreezing: Pour the bacterial suspension into a sterile culture dish to a thickness of about 0.5 cm and prefreeze at -80°C for 12 h; (3) Vacuum freeze drying: After the bacterial slurry is pre-frozen, freeze-dry it for 24 hours to make the moisture content of the freeze-dried bacterial powder about 3%, thus obtaining freeze-dried powder.

7. The method according to claim 6, characterized in that The activator in step (1) is sodium glutamate with a concentration of 0.05 g / L-0.15 g / L and / or brown algae oligosaccharide with a concentration of 0.1 g / L-0.2 g / L.

8. The freeze-dried powder according to claim 6, characterized in that The freeze-drying protective agent in step (1) is skim milk with a concentration of 30-40 g / 100 mL and / or sucrose with a concentration of 10-14 g / 100 mL.

Citation Information

Cited By

  • Preparation method and application of freeze-dried powder of lactobacillus salivarius

    CN119709554A